Cargando...

Proteolysis Targeting Chimeras (PROTACs) of Anaplastic Lymphoma Kinase (ALK)

Anaplastic lymphoma kinase (ALK) activation has been associated with many types of human cancer. Significant efforts have been devoted to development of ALK inhibitors to antagonize the kinase activity of ALK. Four ALK inhibitors have been approved by the FDA to date for treating patients with ALK-p...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Eur J Med Chem
Autores principales: Zhang, Chengwei, Han, Xiao-Ran, Yang, Xiaobao, Jiang, Biao, Liu, Jing, Xiong, Yue, Jin, Jian
Formato: Artigo
Lenguaje:Inglês
Publicado: 2018
Materias:
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5924614/
https://ncbi.nlm.nih.gov/pubmed/29627725
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ejmech.2018.03.071
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!